Close Menu

It's a Fight to Watch

The Scientist tells the story of Stephen Heinemann, a neurologist at the Salk Institute, who lost all his funding from the Salk Institute Council Endowment that, along with two NIH grants and private money, funded his mouse lab. Heinemann laid off his staff and now is worried that he'll be next out the door.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.